2025-01-01 2025-12-31 false Capium Accounts Production 1.1 14558991 2025-01-01 2025-12-31 14558991 bus:FullAccounts 2025-01-01 2025-12-31 14558991 bus:Micro-entities 2025-01-01 2025-12-31 14558991 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 14558991 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14558991 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14558991 2025-01-01 2025-12-31 14558991 2025-12-31 14558991 bus:RegisteredOffice 2025-01-01 2025-12-31 14558991 core:WithinOneYear 2025-12-31 14558991 core:AfterOneYear 2025-12-31 14558991 1 2025-01-01 2025-12-31 14558991 bus:Director1 2025-01-01 2025-12-31 14558991 bus:Director1 2025-12-31 14558991 bus:Director1 2024-01-01 2024-12-31 14558991 2024-01-01 14558991 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 14558991 2024-01-01 2024-12-31 14558991 2024-12-31 14558991 core:WithinOneYear 2024-12-31 14558991 core:AfterOneYear 2024-12-31 14558991 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 14558991 core:FurnitureFittings 2025-01-01 2025-12-31 14558991 core:FurnitureFittings 2025-12-31 14558991 core:FurnitureFittings 2024-12-31 14558991 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 14558991 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 14558991 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 14558991 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 14558991 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 14558991 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 14558991 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 14558991 core:Non-currentFinancialInstruments 2025-12-31 14558991 core:Non-currentFinancialInstruments 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14558991
England and Wales
M.SHA MEDICA LTD
Unaudited Financial Statements
Period of accounts Start date: 01 January 2025 End date: 31 December 2025

M.SHA MEDICA LTD Statement of Financial Position As at 31 December 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 1,682 |  |  | 3,330
Current assets |  | 69,185 |  |  | 14,860 |
Creditors: amount falling due within one year |  | (37,597) |  |  | (2,715) |
Net current assets |  |  | 31,588 |  |  | 12,145
Total assets less current liabilities |  |  | 33,270 |  |  | 15,475
Creditors: amount falling due after more than one year |  |  | (350) |  |  | (1,750)
Net assets |  |  | 32,920 |  |  | 13,725
Capital and reserves |  |  | 32,920 |  |  | 13,725
NOTES TO THE ACCOUNTS General Information M.SHA MEDICA LTD is a private company, limited by shares, registered in England and Wales, registration number 14558991, registration address 2 Helena Repton Place, Stoke-On-Trent, Staffordshire, ST4 8ZX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings | 33% Straight Line
2. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Total
| £ |  | £
At 01 January 2025 | 5,535 |  | 5,535
Additions | - |  | -
Disposals | - |  | -
At 31 December 2025 | 5,535 |  | 5,535
Depreciation
At 01 January 2025 | 2,205 |  | 2,205
Charge for year | 1,648 |  | 1,648
On disposals | - |  | -
At 31 December 2025 | 3,853 |  | 3,853
Net book values
Closing balance as at 31 December 2025 | 1,682 |  | 1,682
Opening balance as at 01 January 2025 | 3,330 |  | 3,330
3. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
For the year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 13 May 2026 and were signed by:
-------------------------------- Muqaddas Shafiq Director
1